What You Should Know:
– CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend.
– CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-insured employers and their employees.
CerpassRx: Advancing Specialty Pharmacy Solutions with AI-Driven Savings and Efficiency
CerpassRx by Nomi Health, a prominent pharmacy benefit manager (PBM) based in Dallas-Fort Worth, Texas, delivers a full suite of pharmacy management services, including:
– Prescription Optimization – Tailoring treatments for maximum effectiveness
– Flexible Formulary Designs – Customizing drug lists to support varied clinical and cost needs
– Personalized Member Support – Enhancing patient engagement and assistance
– Mail and Specialty Pharmacy Programs– Streamlining delivery and specialty drug access
Amid rapidly rising healthcare costs, specialty medications have emerged as a major expenditure, accounting for over half of total drug spending in the U.S. Health plans and self-insured employers are increasingly turning to PBMs like CerpassRx for innovative strategies to control these costs while improving the patient experience.
The newly launched CerpassRx platform leverages **Waltz Connect** by Waltz Health—a comprehensive, AI-driven solution that maximizes savings and flexibility. With a competitive network of national and regional specialty pharmacies, the platform dynamically routes specialty prescriptions to the most cost-effective and clinically appropriate pharmacies. This intelligent marketplace ensures patients and payers receive the optimal combination of price, service, and clinical outcomes.
The Intelligent Specialty Engine embedded within the platform goes beyond cost savings by enhancing the member experience. By reducing delays, improving accuracy, and refining pharmacy selection, members experience faster access to their medications without the typical complexities associated with specialty drugs. Additionally, the platform’s advanced data analytics offer real-time insights, allowing health plans and employers to make informed, cost-effective decisions.
“CerpassRx is a PBM innovator that has created a unique approach that targets high-cost specialty drug spend,” said Waltz Health President Jeff Park. “We’re proud to work with its team to build a new model that focuses on patient affordability and access while also managing both the care and cost of their complex conditions.”
